Suchergebnisse - "Shi, Yuankai"

PubPharm (529)

101

Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma

enthalten in: The New England journal of medicine | 2022

von Wang, M. | Jurczak, W. | Jerkeman, M. | +129

CommentIn: Nat Rev Clin Oncol. 2022 Aug;19(8):494. - PMID 35750854

102

Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017) : A multicentre prospective study

enthalten in: The Lancet regional health. Western Pacific | 2022

von Shi, Y. | Zhang, X. | Wu, G. | +14

103

Prevalence and management of pain in lung cancer patients in northern China : A multicenter cross-sectional study

enthalten in: Thoracic cancer | 2022

von Zhang, B. | Li, X. | Ma, Z. | +17

104

Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis

enthalten in: Cancer immunology immunotherapy | 2022

von Chen, H. | Feng, Y. | Zhou, Y. | +3

105

Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis

enthalten in: Cancer immunology immunotherapy | 2022

von Chen, H. | Feng, Y. | Zhou, Y. | +3

106

Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis

enthalten in: Cancer immunology immunotherapy | 2022

von Chen, H. | Feng, Y. | Zhou, Y. | +3

107

Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC

enthalten in: Journal of translational medicine | 2022

von Wang, S. | Lou, N. | Luo, R. | +5

108

Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC

enthalten in: Journal of translational medicine | 2022

von Wang, S. | Lou, N. | Luo, R. | +5

109

Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC

enthalten in: Journal of translational medicine | 2022

von Wang, S. | Lou, N. | Luo, R. | +5

110

Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width : a new prognostic model for diffuse large B-cell lymphoma in the rituximab era

enthalten in: BMC cancer | 2022

von Chen, H. | Zhong, Q. | Zhou, Y. | +10